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Objectives.T oi n v e s t i g a t et h ee ﬀects of proton pump inhibitors (PPIs) and H2 receptor antagonists on ileum motility in rats with
peritonitis and compare changes with control group rats. Methods. Peritonitis was induced by cecal ligation and puncture in 8
rats. Another of 8 rats underwent a sham operation and were accepted as controls. Twenty-four hours later after the operation,
the rats were killed, and their ileum smooth muscle was excised and placed in circular muscle direction in a 10mL organ bath.
Changes in amplitude and frequency of contractions were analyzed before and after PPIs and H2 receptor blockers. Results.P P I
agents decreased the motility in a dose-dependent manner in ileum in both control and intraabdominal sepsis groups. While
famotidine had no signiﬁcant eﬀect on ileum motility, ranitidine and nizatidine enhanced motility in ileum in both control and
intraabdominal sepsis groups. This excitatory eﬀect of H2 receptor antagonists and inhibitor eﬀects of PPIs were signiﬁcantly high
in control group when compared to the peritonitis group. The inhibitor eﬀect of pantoprazole on ileum motility was signiﬁcantly
higher than the other two PPI agents. Conclusions. It was concluded that H2 receptor antagonists may be more eﬀective than PPIs
for recovering the bowel motility in the intraabdominal sepsis situation.
1.Introduction
Sepsis is a systemic response to infection and inﬂammation.
Sepsis syndrome which developing in reaction to sepsis has
constituted one of most important causes of the mortality at
present, despite, widespread use of speciﬁc antibiotics and
other pharmacological agents [1–3].
Sepsis is a syndrome that aﬀects the public health system
and represents a challenge to health care providers and man-
agers. Epidemiological data revealed a high incidence of
sepsis in patients hospitalized in intensive care units (ICU)
compared with the occurrence of disease in general popula-
tion [4, 5].
Dysmotility of the gastrointestinal tract is a major com-
plication in critically ill patients in intensive care units
(ICU). Most of the time, this dysmotility manifests itself as
inhibition of gastrointestinal motility, and rarely as hy-
permotility [6]. Impaired motility in critically ill patients
can be caused by intestinal ischemia, electrolyte imbalances,
peritoneal injury, abdominal surgery, lower-lobe pneumo-
nia, pancreatitis, cholecystitis, intraabdominal abscesses, and
medications (opiates, dopamine, diltiazem, verapamil, and
anticholinergics) [7].
Many critically ill patients in ICU require acid suppres-
sive agents. Proton pump inhibitors (PPIs) are commonly
used in the (ICU) for stress ulcer prophylaxis therapy given
their potent acid inhibitory eﬀect, an eﬃcacy that is at least
as good as, and perhaps better than, that of H2 receptor
blockers therapy, and a benign safety proﬁle [8, 9]. Although
it is well known that peritonitis aﬀects gastrointestinal
system motility, patients suﬀering from peritonitis are good
candidates for ICUs; however, PPIs and H2 receptor blockers
are commonly used agents in these units; there is very little
information about the eﬀects of acid suppressive agents
(ASD) on the intestinal motility in the patients. In this study,
we aimed to investigate the eﬀects of PPIs and H2 receptor
blockers on ileum motility in both normal and peritonitis
situations.2 Gastroenterology Research and Practice
2.MaterialsandMethods
2.1. Animal Preparation. Sixteen male Wistar albino rats
each weighing approximately 280g were used in this study.
The study was approved by the ethics committee of the
Cumhuriyet University School of Medicine. Cecal ligation
a n dp u n c t u r ew e r eu s e da st h ep e r i t o n i t i sm o d e l[ 10]. Ani-
mals were divided into two groups. The ﬁrst group (n = 8)
consisted of sham surgical controls that underwent the same
procedure as the peritonitis group, such that laparotomy
was performed under anesthesia, with manipulation of the
cecum, but cecum ligation and puncture were not per-
formed. Rats in the second group (n = 8) underwent cecal
puncture and ligation as previously described by Richardson
et al. [11]. Animals were anesthetized with intramuscular
injections of 3mg/kg xylazine (Rompun, Bayer, Istanbul,
Turkey), and 90mg/kg ketamine (Ketalar, Pﬁzer, Istanbul,
Turkey), following which, laparotomy was performed via
a 2cm midline incision and the cecum was exposed. The
cecum was ligated using 4/0 silk suture material just below
the ileocecal valve, so that intestinal continuity was main-
tained. Then, the cecum was punctured using an 18-gauge
needle in three locations, 1cm apart, on the antimesenteric
surfaceofthececum,andcecumwasgentlycompresseduntil
feces were extruded. The cecum was replaced into the peri-
toneal cavity, and the abdomen was then closed. A summary
of the experimental treatments is presented below, Groups:
Group I (n = 8): sham surgical controls; Group II (n =
8): peritonitis group. At the second laparotomy, 24h later,
the rats were killed by cervical dislocation. The abdomen
was opened with a midline incision, and the ileum was
removed and placed in previously aerated (95% O2 and 5%
CO2) Krebs bicarbonate solution (composition in mmol/L:
NaCl, 120; KCl, 4.6; CaCl2,2 . 5 ;M g C l 2,1 . 2 ;N a H C O 3, 22;
NaH2PO4, and glucose 11.5). Whole full-thickness segments
of ileum were placed in circular direction in a 10mL tissue
baths, ﬁlled with preaerated Krebs bicarbonate solution
(KBS) at 37◦C. The upper end of the preparation was tied
to an isometric transducer (Grass FT 03, Quincy, Mass,
USA) and preloaded with 1–1.5g. Tissues were allowed to
equilibrate for 30min.
2.2. In Vitro Muscle Contractility Studies. Muscle segments
from each group were contracted with 80mmol/L KCl to
ensure that they worked properly at the beginning and end
of each experiment. At the beginning of each experiment,
80mmol/L KCl was added to the organ bath, and the con-
traction was considered as reference response. Subsequently,
the amplitude of spontaneous contractions of the isolated
ileum muscle segments was calculated as a percentage of
the contraction induced by KCl (80mmol/L) from both
control and peritonitis groups. Changes in the frequency
(number/min) of spontaneous contractions were expressed
asthenumberofcontractionsfor10minintervals.Following
the KCl response, smooth muscle segments were allowed to
equilibrate for 30min before addition of cumulative doses
of omeprazole (10−8–10−4mol/L), pantoprazole (10−8–
10−4mol/L), lansoprazole (10−8–10−4mol/L), and famoti-
dine (10−8–10−4mol/L), ranitidine (10−8–10−4mol/L), and
nizatidine (10−8–10−4mol/L). The changes of amplitudes of
the contractions induced by these compounds from both
controlandperitonitisgroupswerecalculatedasthepercent-
age of the initial spontaneous contractions. Changes in the
frequency of spontaneous contractions were expressed as the
number of spontaneous contractions for 10min after drug
application. Isometric tensions were recorded on a Grass
model 79 E polygraph.
2.3. Drugs. The following compounds were used: omepra-
zole, pantoprazole, lansoprazole, and famotidine, ranitidine,
nizatidine (Aldrich Chemicals Co., USA). All drugs were
dissolved in distilled water. All drugs were freshly prepared
on the day of the experiment.
2.4. Data Analysis. A l ld a t aa r ee x p r e s s e da sm e a n± SEM.
Statistical comparisons between groups were performed
using general linear models of analysis of variance (ANOVA)
followed by the Tukey test and a t-test when appropriate, and
P values of less than 0.05 were considered to be statistically
signiﬁcant.
3. Results
Contractions induced by 80mmol/L KCl were not signiﬁ-
cantlydiﬀerentbetweentheperitonitisgroupandthecontrol
group in isolated ileum smooth muscle segments which
indicated that muscle segments from both groups worked
properly (Figure 1(a)).
The mean amplitude of the spontaneous contractions
was % 84.5 ± 3.4 of KCl in the control and % 50.2 ± 6.5
of KCl in the peritonitis group, respectively. The number of
spontaneous contractions obtained in 10min in the control
group was 31.7 ± 2.6 and 20.8 ± 1.9 in the peritonitis
group.Boththeamplitudeandthefrequencyofspontaneous
contractions of ileum smooth muscle segments were signif-
icantly low in the peritonitis group when compared to the
control group (P<0.05, Figures 1(b) and 1(c)).
The amplitudes of spontaneous contractions of ileum
muscle segments were studied after adding omeprazole,
pantoprazole, and lansoprazole to the organ bath. Omepra-
zole (10−8–10−4mol/L), pantoprazole (10−8–10−4mol/L),
and lansoprazole (10−8–10−4mol/L), signiﬁcantly decreased
the amplitude of spontaneous contractions, starting from
10−6mol/L for omeprazole and lansoprazole, in control
group. However, this decreasing eﬀect started at the con-
centration of 10−5mol/L in peritonitis group. In both
groups,theinhibitoreﬀectofpantoprazoleonileummotility
was signiﬁcantly higher than omeprazole and lansoprazole
(Figures 2(a) and 2(b);( Table 1)( P<0.05).
The frequency of spontaneous contractions of ileum
muscle segments was studied after adding omeprazole, pan-
toprazole, and lansoprazole to the organ bath. Omeprazole
(10−8–10−4mol/L), pantoprazole (10−8–10−4mol/L), and
lansoprazole (10−8–10−4mol/L) was signiﬁcantly decreased
the frequency of spontaneous contractions starting from
10−5mol/L for omeprazole and lansoprazole, in isolated
ileum muscle segments, in both control and peritonitisGastroenterology Research and Practice 3
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Figure 1: (a) KCl (80mmol/L) induced contractions of isolated ileum muscle segments in control and peritonitis groups. (b) Changes in the
amplitude of spontaneous contractions of the isolated ileum muscle segments. Amplitudes were calculated as a percentage of the contraction
induced by KCl (80mmol/L) from both control and peritonitis groups. (c) Changes in the frequency of spontaneous contractions of the
isolated ileum muscle segments. Frequencies were expressed as the number of contractions for 10min from both control and peritonitis
groups. (∗P<0.05 versus control group; analysis of variance followed by Tukey test.)
groups (P<0.05). In both groups, the inhibitor eﬀect
of pantoprazole on ileum frequency, which was starting
from 10−6mol/L, was signiﬁcantly higher than omeprazole
and lansoparazole. The inhibitor eﬀect of PPIs on frequen-
cy of ileum smooth muscles was higher in control group
when compared to peritonitis group (Figures 2(c) and 2(d);
(Table 1)( P<0.05).
The amplitude of spontaneous contractions of ileum
muscle segments was studied after adding famotidine, rani-
tidine and nizatidine to the organ bath. Famotidine (10−8–
10−4mol/L) caused no signiﬁcant change on amplitude of
spontaneouscontractionsinisolatedileummusclesegments,
in both control and peritonitis groups. On the other
hand, ranitidine (10−8–10−4mol/L) and nizatidine (10−8–
10−4mol/L) signiﬁcantly increased the amplitude of spon-
taneous contractions starting from 10−6mol/L in isolated
ileum muscle segments, in both control and peritonitis
groups, in a concentration-dependent manner. The increase
in amplitude was higher in control group when compared to
peritonitis group (Figures 3(a) and 3(b); P<0.05).
The frequency of spontaneous contractions of ileum
muscle segments was studied after adding famotidine, ran-
itidine, and nizatidine to the organ bath. Famotidine (10−8–
10−4mol/L), ranitidine (10−8–10−4mol/L), and nizatidine
(10−8–10−4mol/L) caused no signiﬁcant change on fre-
quencyofspontaneouscontractionsinisolatedileummuscle
segments in both control and peritonitis groups. There was
also no signiﬁcant diﬀerence between famotidine, ranitidine,
and nizatidine in terms of eﬀecting frequency of ileum mus-
cle segments (Figures 3(c) and 3(d), P>0.05).
4. Discussion
The ﬁrst ﬁnding of our study is that peritonitis altered the
spontaneous activity of the rat ileum by decreasing both
the amplitude and the frequencies of the contractions in
accordance with the previous studies reported recently by
Koyluoglu et al. and Aydın et al. [12, 13]. The main ﬁndings
are that PPIs, omeprazole, pantoprazole, and lansoprazole
decreasedamplitudeandfrequencyofrhythmiccontractions4 Gastroenterology Research and Practice
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Figure 2: Amplitudes of the contractions induced by omeprazole, pantoprazole, and lansoprazole. (a) Control group; (b) peritonitis group;
both were calculated as the percentage of the initial contractions. (∗P<0.05 versus initial contractions, aP<0.05 versus omeprazole and
lansoprazole; analysis of variance followed by Tukey test.) Changes induced by omeprazole, pantoprazole, and lansoprazole in the frequency
of spontaneous contractions. (c) Control group; (d) peritonitis group. Both were expressed as the number of contractions for 10min.
(∗P<0.05 versus initial contractions, aP<0.05 versus omeprazole and lansoprazole; analysis of variance followed by Tukey test.)
Table 1: Eﬀects of proton pump inhibitors and H2 receptor antag-
onist agents on amplitude and frequency of the spontaneous con-
tractions.
Amplitude Frequency
Omeprazole Decreased Decreased
Pantoprazole Decreased Decreased
Lansoprazole Decreased Decreased
Famotidine No signiﬁcant change No signiﬁcant change
Ranitidine Increased No signiﬁcant change
Nizatidine Increased No signiﬁcant change
in both control and peritonitis groups. Therefore, H2 re-
ceptor antagonists, famotidine, ranitidine, and nizatidine
increased motility in the ileum smooth muscle while they
have no eﬀect on frequency of ileum motility.
Abdominal sepsis or peritonitis is also a major cause of
morbidity andmortality insurgicalintensive careunits. Gas-
trointestinal dysmotility commonly accompanies peritonitis,
and those patients suﬀering peritonitis are also exposed to
the additive eﬀects of sedatives or anesthetics in surgical
intensive care units [13].
PPIsandH2 receptorantagonistsarethemostcommonly
used drugs in acid-related diseases, for example, peptic ulcer,
gastroesophageal reﬂux diseases (GERD), and Zollinger-
Ellison syndrome. PPIs have been extensively studied for
both eﬃcacy and safety [11]. Of note, in several studies eval-
uating short-term treatment with PPIs, the investigators
reported that it caused a delay in gastric emptying of solid
m e a l si nh e a l t h ys u b j e c t s[ 14, 15]. However, the eﬀects of
PPIs on small bowel motility or transit are unclear; it is
known that PPIs produce a dose-dependent delay in gastricGastroenterology Research and Practice 5
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Figure 3: Amplitudes of the contractions induced by famotidine, ranitidine, and nizatidine. (a) Control group; (b) peritonitis group; both
werecalculatedasthepercentageoftheinitialcontractions.(∗P<0.05versusinitialcontractions;analysisofvariancefollowedbyTukeytest.)
Changes induced by famotidine, ranitidine, and nizatidine in the frequency of spontaneous contractions. (c) Control group; (d) peritonitis
group. Both were expressed as the number of contractions for 10min.
emptying [10]. Investigators have previously shown that one
month of PPI therapy was associated with reduced gallblad-
dermotility[16].ThismayshowthatPPIsreducegallbladder
motility and cause gallstones. Our results seem consistent
with these previous studies. In our study we found that
omeprazole, pantoprazole, and lansoprazole signiﬁcantly
decreased the amplitude and frequency of spontaneous
contractions in both control and peritonitis groups. In both
groups,theinhibitoreﬀectofpantoprazoleonileummotility
was signiﬁcantly higher than omeprazole and lansoparazole.
In peritonitis group, motility had been decreased by the
peritonitis conditions itself. So, administration of PPIs in
peritonitis group worsened the motility.
H2 receptor antagonists, in addition to their well-known
gastric acid inhibitory eﬀect, have prokinetic properties
as well, thus stimulating gastrointestinal contractions and
accelerating gastric emptying at gastric antisecretory doses
[17, 18]. In fact, it has been suggested that some H2-receptor
antagonists are more eﬀective than several prokinetics in
improving dyspeptic symptoms, gastric emptying and dis-
tention [19]. The prokinetic activity of the above agents
derivesmainlyfromtheiranticholinesteraseactivity.Itiswell
known that in, intestinal smooth muscle, acetylcholine and
its related stimulants produce contractionby activating mus-
carinic receptors (M2 and M3)[ 20]. In the study conducted
by Unno et al., it has been suggested that the order of agonist
eﬃcacy for depolarization is the same as for Ca2+ store
release that represents M3 activation. This ﬁnding suggests
thatM3 activationmaycontributetovoltage-dependentCa2+
entry into the cell by potentiating the M2-mediated cationic
current through both the indirect (Ca2+ store release) and
direct pathways and so in turn by increasing the size of6 Gastroenterology Research and Practice
depolarization and the frequency of spike discharges. The
idea is supported by our previous observation that depletion
of Ca2+ stores attenuated carbachol-evoked depolarizations
in single ileal muscle cells [21].
Indeed, in vivo [22]a n din vitro studies [23] have shown
that most H2-receptor antagonists exhibit weak or strong
anticholinesterase activity, ranitidine and nizatidine being
the more potent among the H2-receptor antagonists with
respect to acetylcholinesterase inhibition [24]. The ampli-
tude responses obtained with ranitidine and nizatidine were
consistent with these data. In our study, in contrast to
other H2 receptor antagonists, famotidine had no eﬀect on
amplitude in ileum smooth muscles. This may be related to
diﬀerent antimuscarinic eﬀects proﬁle of these H2 receptor
antagonists.
Maher et al. [25] revealed that ranitidine shows its eﬀects
by promoting amplitude responses and does not have any
eﬀect on frequency responses. This ﬁnding is consistent with
our results related to frequency. Any of H2 receptor antag-
onists we used had no eﬀect on frequency responses in ileum
smooth muscle.
In conclusion, PPIs and H2 receptor antagonists have
contrary eﬀects on ileum motility in both normal and peri-
tonitis situations. The eﬀects of these agents were parallel
in control and peritonitis groups. The clinical implications
of these ﬁndings need to be tested in surgical intensive care
units, which might help in choosing the most appropri-
ate drug for preventing the acid-related complications of
patients with peritonitis.
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